We will begin diabetes treatment with the medication Mounjaro at our clinic starting on March 25, 2025.
Following the lifting of the shipment restrictions on the diabetes medication Mounjaro, we will begin insurance-covered treatment using self-injection of Mounjaro, a long-acting GIP/GLP-1 receptor agonist.
Mounjaro has an appetite-suppressing effect, which also helps reduce body weight in cases of obesity. The risk of side effects such as hypoglycemia is also low. Patients diagnosed with diabetes can receive a prescription under insurance coverage, so please feel free to consult with us.